WST

West Pharmaceutical ServicesF

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

25%

Probability

Target price

$22.10

Analysis reference price unavailable

Analysis 2026-01-15 · RankAlpha Sentiment AI

Most likely

Base case

55%

Probability

Target price

$15.19

Analysis reference price unavailable

Analysis 2026-01-15 · RankAlpha Sentiment AI

B-

Bear case

20%

Probability

Target price

$8.29

Analysis reference price unavailable

Analysis 2026-01-15 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-01-15

AI commentary

Market sentiment is mixed: public aggregators show wide analyst-target dispersion versus the anchor, creating both upside expectations and caution [#SERP-1]. Near-term tone is watchful ahead of earnings and potential analyst rebasings that could drive volatility [#SERP-3]. Longer-term sentiment hinges on margin recovery and successful capacity ramps with major pharma clients [#SERP-6].

RankAlpha Sentiment AI - 2026-01-15

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-15eventNext quarterly earnings announcement (assumed window)High impact

Upcoming quarterly earnings could drive re-rating if revenue/gross margins beat expectations; date estimated by analyst on 2026-01-15 due to no public filing date (assumption: quarter-end earnings window) [#SERP-3].

2026-04-15catalystAnalyst coverage revision / consensus repricingHigh impact

Near-term analyst upgrades or downgrades could trigger flows and volatility; date estimated by analyst on 2026-01-15 aligned to typical post-earnings revision window (assumption: repricing within next quarter) [#SERP-1][#SERP-2].

2027-01-15catalystNew product / capacity ramp with large pharma customersHigh impact

Successful multi-year capacity ramp or adoption of new containment/delivery components by major pharma customers would expand addressable market and margins; estimated by analyst on 2026-01-15 (assumption: multi-year commercial rollout) [#SERP-6].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-01-15 • Updated nightlySource: Internal modelMethodology